The Latest
-
The TJX Companies Inc. (TJX): Citigroup Places a Neutral Rating with Potential Upside
-
Merck & Co., Inc. (MRK): Morgan Stanley Upgrades to Overweight with $179 Price Target
-
John B. Sanfilippo & Son, Inc. (JBSS): Analyst Upgrades to Buy with Upside Potential
-
The TJX Companies, Inc. (TJX) Receives Accumulate Rating: Assessing Investment Potential